Lucide Ledger

A filing-first public record from Lucide House.

Issue 000 | U.S. Pilot | US

BBLG

Bone Biologics Corp

Passing Verified 10-Q | 2026-05-14 Filing currency: USD
Open Filing Back to Register
Margin of Safety 45.4%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
4,979,305USD
Total Liabilities
309,386USD
NCAV
4,669,919USD
Cash
4,530,040USD
NCAV per share
2.60USD/share
Evidence
10 annual | 20 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one BBLG, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue n/a n/a n/a n/a n/a 1,070,000,000 1,070,000,000 1,070,000,000 1,070,000,000 1,070,000,000
Operating Income -3,234,942 -4,219,161 -9,428,303 -3,665,173 -1,101,476 -825,014 -2,447,434 -2,790,889 -2,626,592 -17,849,237
Net Income -3,108,991 -4,112,420 -8,948,731 -1,484,620 -1,610,685 -1,824,690 -3,424,811 -4,430,399 -59,000,000 46,900,000
Cash From Operations -2,691,150 -4,124,935 -9,555,904 -3,566,913 -1,228,586 -426,933 -3,251,229 -4,104,884 -3,330,096 -7,327,845
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents n/a n/a n/a 7,538,312 6,675,365 n/a 24,145 955,374 690,279 620,375
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 5,796,135 3,861,369 3,737,763 8,495,237 n/a n/a 30,827 1,040,662 795,513 972,843
Total Assets 5,796,135 3,861,369 3,737,763 8,495,237 6,675,365 0 30,827 1,040,712 795,659 973,085
Total Current Liabilities 418,587 377,712 831,402 2,547,929 99,909 13,692,310 578,447 9,638,887 961,795 3,324,893
Total Liabilities 418,587 377,712 831,402 2,547,929 99,909 13,692,310 11,898,447 9,638,887 9,191,482 9,607,141
Shareholders Equity 5,377,548 3,483,657 2,906,361 5,947,308 6,575,456 -13,692,310 -11,867,620 -8,598,175 -8,395,823 -8,634,056
Shares Outstanding 1,795,260 2,953,982 534,238 15,301,986 10,350,574 30,682,590 30,682,590 26,448,881 43,280,795 38,828,607
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 1,174,869 1,517,235 263,137 47,658 n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Basic 1,174,869 1,517,235 263,137 47,658 n/a n/a n/a n/a n/a n/a
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0
Operating Income -805,054 -733,105 -715,274 -748,077 -1,038,486 -1,554,938 -951,021 -809,666 -903,536 -1,160,008 -2,080,890 -3,039,868 -3,147,537 -1,288,693 -1,219,277 -500,781 -656,422 -458,882 -229,789 -231,881
Net Income -765,988 -684,643 -666,737 -740,519 -1,017,092 -1,521,715 -941,002 -783,733 -865,970 -1,549,885 -1,919,709 -1,769,238 -3,709,899 893,460 -1,219,277 -469,304 -689,499 -177,737 -509,303 -491,898
Cash From Operations -804,282 -714,762 -591,384 -458,879 -926,125 -1,353,497 -572,162 -895,865 -1,303,411 -2,018,015 -2,555,223 -3,632,673 -1,349,993 -1,950,791 -395,279 -360,064 -860,779 -186,852 -277,770 -635,981
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6,188,319 7,538,312 n/a n/a 5,814,586 6,675,365 3,374 4,438
Total Current Assets 4,979,305 5,796,135 6,350,799 7,002,216 3,162,060 3,861,369 4,065,818 3,193,464 3,839,574 3,737,763 n/a n/a n/a 8,495,237 n/a n/a n/a n/a n/a n/a
Total Liabilities 309,386 418,587 334,282 406,142 251,158 377,712 273,402 284,507 164,626 831,402 1,183,235 1,930,255 4,011,354 2,547,929 799,475 70,636 54,913 99,909 15,177,651 14,620,393
Shares Outstanding 1,795,260 1,795,260 1,795,260 1,685,260 3,271,042 2,953,982 2,096,740 1,315,489 1,016,489 534,238 3,134,391 3,134,391 16,702,912 15,301,986 10,350,579 10,350,579 10,350,579 10,350,574 12,273,036 30,682,590
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 1,795,260 1,174,869 1,795,097 557,787 3,183,191 1,517,235 1,753,409 1,168,423 660,928 263,137 3,134,391 1,047,022 67,211 47,658 345,019 345,019 n/a n/a n/a n/a
Weighted Avg Shares Basic 1,795,260 1,174,869 1,795,097 557,787 3,183,191 1,517,235 1,753,409 1,168,423 660,928 263,137 3,134,391 1,047,022 16,115,577 47,658 10,350,579 10,350,579 10,350,579 n/a 2,911,333 2,911,333
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 4,979,305USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001419554/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001419554\companyfacts.json
Total Liabilities 309,386USD us-gaap:Liabilities 2026-03-31 1.00 sec/companyfacts/cik=0001419554/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001419554\companyfacts.json
Cash n/a derived 2026-03-31 n/a n/a
Shares Outstanding 1,795,260 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001419554/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001419554\companyfacts.json
NCAV 4,669,919USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.60USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 45.4% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
CIK
0001419554
Company ID
n/a
Selected Annual Source
n/a
Selected Quarterly Source
n/a
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
22
Imported At
2026-07-04T23:04:25+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001493152-26-023163
CIK
0001419554
Mary Filing Date
2026-05-14
Filing Currency
USD
Internal Discount
45.4%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-14; mary_accession=0001493152-26-023163; mary_cik=0001419554; gnni_supporting_filing_date=2026-05-14; internal_discount=0.454108; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive